Abstracts tagged "Rheumatic disease"

Abstract Number: 187 • 2015 ACR/ARHP Annual Meeting
Detection of Power Doppler Ultrasound Signals in Rheumatic Diseases Using Superb Microvascular Imaging (SMI): Comparison with Conventional Power Doppler Ultrasound
Kazuhiro Yokota¹, Takuma Tsuzuki Wada², Yuji Akiyama² and Toshihide Mimura³, ¹Department of Rheumatology & Applied Immunology, Faculty of Medicine, Saitama Medical University, Irama, Japan, ²Department of Rheumatology & Applied Immunology, Faculty of Medicine, Saitama Medical University, Iruma, Japan, ³Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan
Background/Purpose: The detection of power Doppler (PD) ultrasound signals in joints may be considered as the presence of joint inflammation, i.e., synovitis which is a…
Abstract Number: 832 • 2015 ACR/ARHP Annual Meeting
The Validity and Reliability of Online Obituaries As a Source of Mortality Data
Medha Soowamber¹, John T. Granton², Fatemeh Bavaghar-Zaeimi³ and Sindhu R. Johnson^4,5, ¹Rheumatology, University of Toronto/ Toronto Western Hospital, Toronto, ON, Canada, ²Medicine, Univeristiy Health Network Pulmonary Hypertension Programme, Toronto General Hospital and University of Toronto, Toronto, ON, Canada, ³Rheumatology, Toronto Scleroderma Program, Toronto Western Hospital and Mount Sinai Hospital, Toronto, ON, Canada, ⁴Toronto Scleroderma Program, Division of Rheumatology, Toronto Western Hospital, Mount Sinai Hospital, Institue of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, ⁵Institute of Health Policy, Management and Evaluation,, University of Toronto, Toronto, ON, Canada
Background/Purpose: Loss to follow-up is a major threat to the conduct of chronic disease cohort research. Tracking the survival status of patients who are lost…
Abstract Number: 1422 • 2014 ACR/ARHP Annual Meeting
Demographic Differences in Health Related Information Technology Use Among Patients with Rheumatic Diseases
David Mackey¹, Aseem Bharat², Lang Chen³, Ben Nowell⁴, Liana Fraenkel⁵, Peter J. Embi⁶, Kenneth G. Saag⁷, James Willig⁸, Seth Ginsberg⁹, Ruth McConnell² and Jeffrey R. Curtis², ¹Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL, ³Medicine, University of Alabama at Birmingham, Birmingham, AL, ⁴Creaky Joints/Global Healthy Living Foundation, Upper Nyack, NY, ⁵Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare Systems, New Haven, CT, ⁶Biomedical Informatics & Internal Medicine, The Ohio State University, Columbus, OH, ⁷Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, ⁸Med - Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, ⁹CreakyJoints/Global Healthy Living Foundation, Upper Nyack, NY
Background/Purpose: Use of the Internet and mobile technologies can be a valuable resource for patients with rheumatic diseases who are seeking health-related information, allowing patients…
Abstract Number: 951 • 2014 ACR/ARHP Annual Meeting
Safety, Tolerability, and Functional Activity of ABT-122, a Dual TNF- and IL-17A–Targeted DVD-Ig™, Following Single-Dose Administration in Healthy Subjects
Heikki Mansikka¹, Melanie Ruzek², Margaret Hugunin², Alexander Ivanov², Alyssa Brito², Anca Clabbers², Carolyn Cuff³, Chung-Ming Hsieh², Martin Okun¹, Renee Heuser¹, David Carter¹, Barbara Hendrickson¹, Dipak Pisal¹, Sandra Goss¹, Jia Liu¹, Charles Locke¹, Nasser Khan¹ and Robert Padley¹, ¹AbbVie, Inc, North Chicago, IL, ²AbbVie, Inc, Worcester, MA, ³Immunology, AbbVie, Inc, Worcester, MA
Background/Purpose: Several lines of evidence indicate that greater clinical efficacy and protection of joints may be possible in patients with RA by neutralizing TNF and…
Abstract Number: 2035 • 2013 ACR/ARHP Annual Meeting
Description Of 142 Cases Of Relapsing Polychondritis Followed In a Single Center Since 2000
Jeremie Dion^1,2, Nathalie Costedoat-Chalumeau³, Damien Sene⁴, Judith Cohen-Bittan⁵, Gaëlle Leroux⁶, Camille Francès⁷ and Jean-Charles Piette⁸, ¹Faculté paris 7 Denis-Diderot, Paris, France, ²Internal medecine, Hopital Cochin, Paris, France, ³Internal Medicine, Hopital Cochin, Paris, France, ⁴Internal Medicine, Hopital Lariboisière, Paris, France, ⁵Service de medecine gériatrique, CHU Pitié-Salpêtrière, Paris, France, ⁶Department of Internal Medicine 1, CHU Pitié-Salpêtrière, Paris, France, ⁷Service de Dermatologie, Hopital Tenon, Paris, France, ⁸Department of Internal Medicine 1., CHU Pitié-Salpêtrière, Paris, France
Background/Purpose: Relapsing polychondritis (RP) is a rare condition characterized by recurrent inflammation of cartilaginous tissues and systemic manifestations. Data on prognosis available from the latest…
Abstract Number: 1952 • 2013 ACR/ARHP Annual Meeting
The Value Of An Automated Ultrasound System In The Detection Of Synovitis
Ruediger Mueller¹, Mathias Gruenke², Joerg Wendler³, Florian Schuch³, Karina Hofmann-Preiss⁴, Ina Boettger⁴, Ruediger Jakobs⁵, Hendrik Schulze-Koops⁶ and Johannes von Kempis¹, ¹Rheumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, ²Division of Rheumatoloy, Medizinische Klinik IV, University of Munich, Munich, Germany, ³Schwerpunktpraxis Rheumatologie, Erlangen, Germany, ⁴Institut für bildgebende Diagnostik und Therapie, Erlangen, Germany, ⁵Siemens AG, Erlangen, Germany, ⁶Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany
Background/Purpose: The detection of joint swelling caused by synovitis is important for the diagnosis and assessment of inflammatory arthritis. Ultrasound (US) and MRI have proven…
Abstract Number: 1848 • 2013 ACR/ARHP Annual Meeting
Human Gingiva-Derived Mesenchymal Stromal Cells Inhibit Graft-Versus-Host Disease Through CD39 and IDO
Song Guo Zheng¹, Maogeng Chen¹, Dong Dong Chen², Jian Gu³ and Yi Shen⁴, ¹Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, ²Medicine, Zhoushan Hospital at Zhejiang Province, Zhoushan, China, ³Medcine, University of Southern California Keck School of Medicine, Los Angeles, CA, ⁴Medicine, Shanghai East Hospital at Tongji University, Shanghai, China
Background/Purpose: We recently have reported that human-derived gingival mesenchymal stem cells (GMSC) have strong capacity to suppress immune responses and T cell-mediated collagen-induced arthritis, however,…
Abstract Number: 59 • 2012 ACR/ARHP Annual Meeting
A Staggering Burden of Pain and Rheumatic Disorders in India: A National Bone & Joint Decade India Community Oriented Program for Control of Rheumatic Disease Survey 2006-2011
Arvind Chopra¹, R. Ghorpade¹, S. Sarmukkadam², VL Joshi¹, AJ. Mathews³, L. Gauri⁴, A. Rahim⁵, K. Datta⁶, S. Chaturvedi⁷, B. Thakuria⁸, A. Mahajan⁹, R. Singh¹⁰, A. Ghosh¹¹, R. Handa¹², Manjit Saluja¹³, A. Venugopalan¹⁴, V. Kunjeer¹⁴, B. Paul⁵, S. Pal⁶, K. Wangjam¹⁰, T. Kumar¹⁵, CP Rajendran¹⁶, V. Gajalakshmi¹⁷ and K. Mahendranath¹⁸, ¹Rheumatology, Center for Rheumatic Diseases, Pune, India, ²Biostatistics, B J Medical College, Pune, India, ³Government Medical College Hospital, Trivandrum, India, ⁴SP Medical College, Bikaner, India, ⁵Calicut Medical College, Calicut, India, ⁶Advance Rheumatology Clinic, Hyderabad, India, ⁷FRCH, Pune, India, ⁸Guwahati Medical College & Hospital, Guwahati, India, ⁹Government Medical College, Jammu, India, ¹⁰Regional Institute of Medical Sciences, Imphal, Manipur, India, ¹¹Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India, ¹²Department of Rheumatology, AIIMS, New Delhi, India, ¹³Clinical care, Center for Rheumatic Diseases, Pune, India, ¹⁴Center for Rheumatic Diseases, Pune, India, ¹⁵Institute of Post Graduate Medical Education and Research, Kolkata, India, ¹⁶Madras Medical College, Chennai, India, ¹⁷ERC Unit, Chennai, India, ¹⁸Rheumatology clinic, Bangalore, India
Background/Purpose : The maiden COPCORD (Community Oriented Program for Control of Rheumatic Diseases) population survey in village Bhigwan (Pune) findings proposed a high burden of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.